Current Report Filing (8-k)
March 30 2020 - 12:31PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report
(Date of earliest event reported): March 30, 2020
ETHEMA HEALTH
CORPORATION
(Exact name
of registrant as specified in its charter)
Colorado
|
000-15078
|
84-1227328
|
(State
or other jurisdiction of
incorporation
or organization)
|
(Commission
File Number)
|
(IRS
Employer
Identification
No.)
|
1590
South Congress, Palm Springs, Florida 33403
|
(Address
of principal executive offices)
|
(416)
500-0020
|
(Registrant’s
telephone number, including area code)
|
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
[
]
|
|
Written
communications pursuant to Rule 425 under the Securities Act
|
[
]
|
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act
|
[
]
|
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
[
]
|
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
ITEMS
8.01 OTHER EVENTS
On March
25, 2020, the U.S. Securities and Exchange Commission (the “Commission”) issued orders under Section 36 (Release No.
34-88465) of the Securities Exchange Act of 1934 (“Exchange Act”) granting exemptions from specified provisions of
the Exchange Act and certain rules thereunder (the “Order”). The Order provides that a registrant (as defined in Exchange
Act Rule 12b-2) subject to the reporting requirements of Exchange Act Section 13(a) or 15(d), and any person required to make
any filings with respect to such a registrant, is exempt from any requirement to file or furnish materials with the Commission
under Exchange Act Sections 13(a), 13(f), 13(g), 14(a), 14(c), 14(f), 15(d) and Regulations 13A, Regulation 13D-G (except for
those provisions mandating the filing of Schedule 13D or amendments to Schedule 13D), 14A, 14C and 15D, and Exchange Act Rules
13f-1, and 14f-1, as applicable, where certain conditions are satisfied.
Ethem Health Corporation (the “Company”)
is furnishing this Current Report on Form 8-K to indicate its reliance on the Order in connection with the Company’s Annual
Report on Form 10-K for the year ended December 31, 2019 as a result of the circumstances set forth below.
Both the Company key employees
and members of the Auditing firm are affected by travel and work restrictions stemming from the COVID-19 pandemic and as a result,
the Company is unable to complete financial statements and records that it needs to
permit the Company to file a timely and accurate Annual Report on Form 10-K for its year ended December 31, 2019 by
the prescribed date without undue hardship and expense to the Company.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed
on its behalf by the undersigned hereunto duly authorized.
Date:
March 30, 2020
By:
/s/ Shawn E. Leon
Name:
Shawn E. Leon
Title:
CEO
Ethema Health (PK) (USOTC:GRST)
Historical Stock Chart
From Aug 2024 to Sep 2024
Ethema Health (PK) (USOTC:GRST)
Historical Stock Chart
From Sep 2023 to Sep 2024